Apyx Medical (APYX) Cash from Investing Activities (2011 - 2026)
Apyx Medical (APYX) posted Cash from Investing Activities of -$60000.0 for Q1 2026, up 78.18% on a QoQ basis from -$275000.0 in Q4 2025, and down 9.09% year-over-year from -$66000.0 in Q1 2025.
Apyx Medical (APYX) Cash from Investing Activities (2011 - 2026) Analysis & Trends
Apyx Medical's Cash from Investing Activities history runs 16 years deep, the most recent figure standing at -$60000.0 for Q1 2026.
- Quarterly Cash from Investing Activities fell 9.09% year-over-year to -$60000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 million (down 50.81% YoY) and the FY2025 annual result came in at -$1.1 million, down 54.29% from the prior year.
- Cash from Investing Activities was -$60000.0 for Q1 2026 at Apyx Medical, up from -$275000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $7.1 million in Q2 2023 and bottomed at -$519000.0 in Q3 2025.
- A 5-year average of $225176.5 and a median of -$174000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2022 — Cash from Investing Activities sank 1282.76% — and 2023, when it jumped 1873.32%.
- Apyx Medical's Cash from Investing Activities stood at -$142000.0 in 2022, then jumped by 34.51% to -$93000.0 in 2023, then tumbled by 163.44% to -$245000.0 in 2024, then retreated by 12.24% to -$275000.0 in 2025, then soared by 78.18% to -$60000.0 in 2026.
- Business Quant data shows APYX's Cash from Investing Activities at -$60000.0 in Q1 2026, -$275000.0 in Q4 2025, and -$519000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -298.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -475.32 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Apyx Medical | 167.53 Mn | 136.65 Mn | 7.93 Mn | -60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60,000.00 |
| Mar 31, 2026 | -60,000.00 |
| Dec 31, 2025 | -275,000.00 |
| Dec 31, 2025 | -275,000.00 |
| Sep 30, 2025 | -519,000.00 |
| Sep 30, 2025 | -519,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Jun 30, 2025 | -265,000.00 |
| Mar 31, 2025 | -55,000.00 |
| Mar 31, 2025 | -55,000.00 |
| Dec 31, 2024 | -245,000.00 |
| Dec 31, 2024 | -245,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Sep 30, 2024 | -153,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Mar 31, 2024 | -35,000.00 |
| Dec 31, 2023 | -93,000.00 |
| Dec 31, 2023 | -93,000.00 |